The dynamics of tumor and immune responses associated with immune checkpoint blockade are unique and complex. Despite the initial successes of immunotherapy, a low objective response rate due to resistance is still the main challenge in solid tumors, particularly advanced-stage lung cancer.
Watch Now
Current protein biomarkers are only moderately predictive in identifying individuals with mild traumatic brain injury or concussion. Therefore, more accurate diagnostic markers are needed for sport-related concussion.
Watch Now
esc365
After watching this webinar, participants will understand: current clinical evidence for the percutaneous treatment of structural heart disease; indications for the transcatheter treatment of symptomatic, significant aortic valve stenosis or mitral regurgitation; optimal patient selection for left atrial appendage occlusion; and the recommended training pathways for structural heart disease.
Watch Now
Therapeutic discovery and development rely on numerous analytical techniques in order to best position candidate drugs for commercial success. Different analytical technologies are utilized for their respective strengths in maximizing understanding of candidate properties.
Watch Now